Company Analysis

SciSparc Ltd. (SPRC)

Nasdaq: SPRC · Pharmaceutical Preparations · Tel Aviv, IL · filing with the SEC since 2014
Grade3.9
◀ Past 3.3● Present 4.0▶ Future 4.2
3 est.

Who owns SciSparc Ltd.

As filed with the SEC
Holders of 5% or more
0
No Schedule 13D or 13G naming this company is on file.
Directors and officers
9
report now, of 9 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 0 named at left.
Holders of 5% or moreshare of the class, as filed
L.I.A. Pure Capital Ltd.
SCHEDULE 13G/A · filed May 15, 2026 · Ordinary Shares, no par value per share · reported falling below 5%, from 9.26% in Jan 21, 2026
under 5%
Ronen Fatal
SCHEDULE 13G · filed Mar 16, 2026 · Ordinary Shares, no par value per share · reported falling below 5%, from 8.76% in Dec 11, 2025
under 5%
Eli Zamir
SCHEDULE 13G · filed Mar 16, 2026 · Ordinary Shares, no par value per share · reported falling below 5%, from 8.76% in Dec 11, 2025
under 5%
Nissim Daniel
SCHEDULE 13G/A · filed Mar 9, 2026 · Ordinary Shares, no par value per share · reported falling below 5%, from 8.76% in Dec 4, 2025
under 5%
What SPRC reports owning in othersstakes of 5% or more, and other ties
Nexentis Technologies Inc. NXTS
SCHEDULE 13G · filed Oct 24, 2025 · Common Stock, $0.0001 par value per share
18.3%
Insider tradesForm 4
1sales
0purchases
0sales on a scheduled plan
1people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
No open-market trade is on the record for these years.
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 9 on the roster
PersonRole as filedSalesSoldOn a planBuysBought
Shrem Itschakdirector1$000$0
SI Assistanton SPRC · research, not advice